Drug Trial Radar · NCT01100307
A Phase 3 Study To Compare The Efficacy And Safety Of 0.3 MG Pegaptanib Sodium To Sham Injections In Subjects With Diabetic Macular Edema
Last checked: Nov 20, 2026Latest source record: Aug 23, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
243
Actual
Start
May 2010
Primary completion
Aug 2012
Study completion Aug 2012
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Apr 8, 2010
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 20 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study to assess the efficacy of pegaptanib sodium 0.3 mg comparing sham injection and to confirm safety of pegaptanib sodium 0.3 mg in subjects with diabetic macular edema.
Conditions
- Macular Edema
- Diabetic Mellitus
- Retinal Disease
Interventions
pegaptanib sodiumDrug
Intravitreal injection of 0.3 mg every 6 weeks
sham injectionOther
sham injection every 6 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants Who Experience a ≥10 Letter Improvement of Visual Acuity (VA) in Early Treatment Diabetic Retinopathy Study (ETDRS) Chart From Baseline at Week 24: Double Masked PhaseTime frame: Baseline and Week 24
Locations
43 sites in 1 country. Site status is shown where the registry gives one.
Nagoya City University Hospital
Nagoya, Aichi-ken, Japan
Nagoya University Hospital
Nagoya, Aichi-ken, Japan
National Hospital Organization Nagoya Medical Center
Nagoya, Aichi-ken, Japan
Akita University Hospital
Akita, Akita, Japan
Aomori Prefectural Chuo Hospital
Aomori, Aomori, Japan
Chiba University Hospital
Chiba, Chiba, Japan
Juntendo University Hospital Urayasu, Ophthalmology
Urayasu-shi, Chiba, Japan
Hayashi Eye Hospital
Fukuoka, Fukuoka, Japan
Kyushu University Hospital
Fukuoka, Fukuoka, Japan
Murakami Karindo Hospital
Fukuoka, Fukuoka, Japan
Ohshima Hospital of Ophthalmology
Fukuoka, Fukuoka, Japan
St. Mary's Hospital
Kurume, Fukuoka, Japan
Fukushima Medical University Hospital
Fukushima, Fukushima, Japan
Gunma University Hospital
Maebashi, Gunma, Japan
Kimura Eye & Internal Medicine Hospital
Kure, Hiroshima, Japan
Asahikawa Medical College Hospital
Asahikawa, Hokkaido, Japan
Yoshida Eye Hospital
Hakodate, Hokkaido, Japan
Hokkaido University Hospital
Sapporo, Hokkaido, Japan
Hyogo Prefectural Amagasaki Hospital
Amagasaki, Hyōgo, Japan
Kobe City Medical Center General Hospital
Kobe, Hyōgo, Japan
Kohnan Hospital
Kobe, Hyōgo, Japan
Hitachi General Hospital
Hitachi, Ibaraki, Japan
Mito Kyodo General Hospital
Mito, Ibaraki, Japan
Kagawa University Hospital
Kida-gun, Kagawa-ken, Japan
Kagoshima University Hospital
Kagoshima, Kagoshima-ken, Japan
Ideta eye hospital
Kumamoto, Kumamoto, Japan
Kyoto University Hospital
Kyoto, Kyoto, Japan
NTT East Tohoku Hospital
Sendai, Miyagi, Japan
Shinshu University Hospital
Matsumoto, Nagano, Japan
Nara Medical University Hospital
Kashihara, Nara, Japan
Niigata University Medical and Dental Hospital
Niigata, Niigata, Japan
Osaka City University Hospital
Osaka, Osaka, Japan
Osaka general medical center
Osaka, Osaka, Japan
Osaka Saiseikai Izou Hospital
Osaka, Osaka, Japan
Kinki University Hospital, Anesthesiology
Osaka-sayama-shi, Osaka, Japan
Saga Prefectural Hospital Koseikan
Saga, Saga-ken, Japan
Shiga University of Medical Science Hospital
Ōtsu, Shiga, Japan
Seirei Hamamatsu General Hospital
Hamamatsu, Shizuoka, Japan
Nihon University Surugadai Hospital
Chiyoda-ku, Tokyo, Japan
Ochanomizu Inoue Eye Clinic
Chiyoda-ku, Tokyo, Japan
Showing 40 of 43 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.